Related references
Note: Only part of the references are listed.Exquisitely Specific Bisubstrate Inhibitors of c-Src Kinase
Kristoffer R. Brandvold et al.
ACS CHEMICAL BIOLOGY (2015)
Exploiting Atropisomerism to Increase the Target Selectivity of Kinase Inhibitors
Davis E. Smith et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
The ins and outs of selective kinase inhibitor development
Susanne Mueller et al.
NATURE CHEMICAL BIOLOGY (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Practical Lewis Base Catalyzed Electrophilic Chlorination of Arenes and Heterocycles
Sean M. Maddox et al.
ORGANIC LETTERS (2015)
Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration
Frank E. Kwarcinski et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Bivalent inhibitors of protein kinases
Carrie M. Gower et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Qingsong Liu et al.
CHEMISTRY & BIOLOGY (2013)
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Tjeerd Barf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis
Danzhi Huang et al.
BIOINFORMATICS (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Challenge of Atropisomerism in Drug Discovery
Jonathan Clayden et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Structural bioinformatics-based design of selective, irreversible kinase inhibitors
MS Cohen et al.
SCIENCE (2005)
Share Paper
